AIDS-related malignancies

Annals of Medicine

Volumn 30, Issue 4, 1998, Pages 323-344

  Smith, Clay ^a   Lilly, Scott ^a   Mann, Karen P ^a   Livingston, Elizabeth ^a   Myers, Sarah ^a   Lyerly, H Kim ^a   Miralles, G Diego ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AIDS; Anogenital neoplasias; Kaposi's sarcoma; Lymphomas; Malignancies

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS CARCINOMA; BASAL CELL CARCINOMA; CANCER; CLINICAL FEATURE; GERM CELL TUMOR; HEAD AND NECK CARCINOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LIFE EXPECTANCY; LUNG SMALL CELL CANCER; MELANOMA; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PLASMACYTOMA; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; UNITED STATES; UTERINE CERVIX CANCER; WORLD HEALTH ORGANIZATION;

EID: 0031686883     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809029932     Document Type: Review

References (212)

1. Levine A, Meyer P, Begandy M, et al. Development of B-cell lymphoma in homosexual men. Ann Intern Med 1984; 100: 7-13.
2. Kalter S, Riggs S, Cabanillas F, et al. Aggressive non-Hodgkin's lymphoma in immunocompromised homosexual males. Blood 1985; 66: 655-9.
3. Levine A. Lymphoma in acquired immunodeficiency syndrome. Semin Oncol 1990; 17: 104-12.
4. Pluda J, Tarchoan R, Broder S. The occurrence of opportunistic non-Hodgkin's lymphomas in the setting of infection with the human immunodeficiency virus. Ann Oncol 1991; 2 (Suppl 2): 191-200.
5. Kaplan L, Abrams D, Feigal E, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261: 719-24.
6. Levine A. AIDS-associated malignant lymphoma. Med Clin North Am 1992; 76: 253-68.
7. Levine A. Acquired immunodeficency syndrome-related lymphoma. Blood 1992; 80: 8-20.
8. Kaplan L, Northfelt D. Malignancies associated with AIDS. In: Sande M, Volberding P, eds. The Medical Managment of AIDS. Philadelphia: WB Saunders; 1997: 413-39.
9. Shibata D, Brynes RK, Rabinowitz A, et al. Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukaemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1). Ann Intern Med 1989; 111: 871-5.
10. Sternlieb J, Mintzer D, Kwa D, Gluckman S. Peripheral T-cell lymphoma in a patient with the acquired immunodeficiency syndrome. Am J Med 1988; 85: 445.
11. Presant CA, Gala K, Wiseman C, et al. Human immunodeficiency virus-associated T-cell lymphoblastic lymphoma in AIDS. Cancer 1987; 60: 1459-61.
12. Pluda J, Yarchoan R, Jaffe E, et al. Develpment of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med 1990; 113: 276-82.
13. Moore R, Kessler H, Richman D, Flexner C, Chaisson R. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine. JAMA 1991; 265: 2208-11.
14. Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin's lymphoma. Lancet 1991; 337: 805-9.
15. Gail M, Pluda J, Rabkin C, et al. Projections of the incidence of Non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst 1991; 83: 695-701.
16. Monfardini S. Malignant lymphomas in patients with or at risk for AIDS in Italy. Recent Results Cancer Res 1988; 112: 37-45.
17. Monfardini S, Vaccher E, Foa R, Tirelli U. AIDS associated non-Hodgkin's lymphoma in Italy: intravenous drug users versus homosexual men. The Italian Cooperative Group on AIDS-related Tumors (GICAT). Ann Oncol 1990: 203-11.
18. Ziegler L, Beckstead J, Volberding P, et al. Non-Hodgkin's lymphoma in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984; 311: 565-70.
19. Rabkin CS, Hilgartner MW, Hedberg KW, et al. Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA 1992; 267: 1090-4.
20. Monroe J, Silberstein L. HIV-mediated B-lymphocyte activation and lymphomagenesis. J Clin Immunol 1995; 15: 61-8.
21. Friedman D, Cho E, Goldman J, et al. The role of clonal selection in the pathogenesis of autoreactive human B cell lymphoma. J Exp Med 1991; 174: 525-37.
22. Shiramizu B, McGrath M. Molecular pathogenesis of AIDS-associated non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 1991; 5: 323-5.
23. Gaidano G, Pastore C, Lanza C, Mazza U, Saglio G. Molecular pathology of AIDS-related lymphomas. Ann Hematol 1994; 69: 281-90.
24. Yarchoan R, Redfield R, Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. J Clin Invest 1986; 78: 439-47.
25. Schnittman SM, Lane HC, Higgins SE, Folks T, Fauci AS. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 1986: 233: 1084-6.
26. Chirmule N, Kalyanaraman VS, Lederman S, et al. HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6. J Immunol 1993; 150: 2478-86.
27. Henderson E, Miller G, Robinson J, Heston L. Efficiency of transformation of lymphocytes by Epstein-Barr virus. Virology 1977; 76: 152-63.
28. Papadopoulos E, Ladanyi M, Emauel D, et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994; 330: 1185-91.
29. Starzl T, Porter K, Iwatsuki S, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; i: 583-7.
30. Hanto D, Frizzera G, Gajl-Peczalska K, Simmons R. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985; 39: 461-72.
31. Gratama J, Zutter M, Minarovits J, et al. Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int J Cancer 1991; 47: 188-92.
32. Subar M, Neri A, Inghirami G, Knowles DM, Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988; 72: 667-71.
33. Pelicci P, Knowles D, Arlin Z, et al. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. J Exp Med 1986; 164: 2049-76.
34. Shibata D. Biologic aspects of AIDS-related lymphoma. Curr Opin Oncol 1994; 6: 503-7.
35. Pedersen C, Gerstoft J, Lundgren J, et al. HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer 1991; 27: 1416-23.
36. Carbone A, Gloghini A, Volpe R, Boiocchi M, Tirelli U. High frequency of Epstein-Barr virus latent membrane protein-1 expression in acquired immunodeficiency syndrome-related Ki-1 (CD30) - positive anaplastic large-cell lymphomas. Italian Cooperative Group on AIDS and Tumors. Am J Clin Pathol 1994; 101: 768-72.
37. Birx D, Redfield R, Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 1986; 314: 874-9.
38. Laroche C, Drouet EB, Brousset P, et al. Measurement by the polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin's lymphomas. J Med Virol 1995; 46: 66-74.
39. Shibata D, Weiss L, Nathwani B, Brynes R, Levine A. Epstein-Barr Virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 1991; 77: 1527-33.
40. Hamilton-Dutoit S, Rea D, Raphael M, et al. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Am J Pathol 1993; 143: 1072-85.
41. Hummel M, Anagnostopoulos J, Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidency in low- and high-grades types. J Pathol 1995; 175: 263-71.
42. Rea D, Delecluse J, Hamilton-Dutoit S, et al. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. Ann Oncol 1994; 5: S113-6.
43. Rickinson A, Murray R, Brooks J, Griffin H, Moss D, Masucci M. T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv 1992; 13: 53-80.
44. Gavioli R, De Campos-Lima P, Kurilla M, et al. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and eBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Proc Natl Acad Sci U S A 1992; 89: 5862-6.
45. Lombardi L, Newcomb E, Dalla-Favera R. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 1987; 49: 161-70.
46. Rechavi G, Ben-Bassat I, Berkowicz M, et al. Molecular analysis of Burkitt's leukemia in two hemophilic brothers with AIDS. Blood 1987; 70: 1713-7.
47. Cesarman E, Chang Y, Moore P, Said J, Knowles D. Kaposi's sarcoma-associated herpes virus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-91.
48. Laurence J, Astrin S. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proc Natl Acad Sci U S A 1991; 88: 7635-9.
49. Emilie D, Cocumbaras J, Raphael M, et al. Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodefi-ciency virus-seronegative patients. Blood 1992; 80: 498-504.
50. Benjamin D, Knobloch T, Dayton M. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992; 80: 1289-98.
51. Marsh N, Herndier B, Tsuzuki A, et al. Cytokine expression in large cell lymphoma associated with acquired immunodeficiency syndrome. J Interferon Cytokine Res 1995; 15: 261-8.
52. Levine A. Lymphoma complicating immunodeficiency disorders. Ann Oncol 1994; 5: S29-35.
53. Hanto DW. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 1995; 46: 381-94.
54. Pluda J, Venzon D, Tosato G, et al. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 1993; 11: 1099-107.
55. Ballerini P, Gaidano G, Gong J, et al. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 1993; 81: 166-76.
56. Alonso ML, Richardson ME, Metroka CE, et al. Chromosome abnormalities in AIDS-associated lymphadenopathy. Blood 1987; 69: 855-8.
57. Pelicci PG, Knowles DMII, Arlin ZA, et al. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med 1986; 164: 2049-60.
58. Prevot S, Raphael M, Fournier JG, Diebold J. Detection by in situ hybridization of HIV and c-myc RNA in tumour cells of AIDS-related B-cell lymphomas. Histopathology 1993; 22: 151-6.
59. Groopman J, Sullivan J, Mulder C, et al. Pathogenesis of B cell lymphoma in a patient with AIDS. Blood 1986; 67: 612-5.
60. Boyle M, Sculley T, Penny R, et al. The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphoma. Leuk Lymphoma 1993; 10: 17-23.
61. Knowles D. Biologic aspects of AIDS-associated non-Hodgkin's lymphoma. Curr Opin Oncol 1993; 5: 845-51.
62. Meyer P, Yanagihara E, Parker J, Lukes R. A distinctive follicular hyperplasia in the acquired immune deficiency syndrome (AIDS) and the AIDS related complex. Hematol Oncol 1984; 2: 319-47.
63. Lowenthal D, Straus D, Campbell S, Gold J, Clarkson B, Koziner B. AIDS-related lymphoid neoplasia. Cancer 1988; 61: 2325-37.
64. Ioachim P, Dorsett B, Cronin W, Maya R, Wahl S. Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, and viral characteristics of 111 cases. Hum Pathol 1991; 22: 659-73.
65. Roithmann S, Andrieu J. Clinical and biological characteristics of malignant lymphomas in HIV-infected patients. Eur J Cancer 1992; 28A: 1501-8.
66. Ribas A, Bellmunt J, Albanell J, et al. Malignant lymphoproliferative diseases in HIV-seropositive patients. Acta Oncol 1995; 34: 75-82.
67. Cappell M, Botros N. Predominantly gastrointestinal symptoms and signs in 11 consecutive AIDS patients with gastrointestinal lymphoma: a multicenter, multiyear study including 763 HIV-seropositive patients. Am J Gastroenterol 1994; 89: 545-9.
68. Northfelt D, Kaplan L. Clinical manifestations of treatment of HIV related non-Hodgkin lymphoma. Cancer Surv 1991; 10: 121-33.
69. Polish LB, Cohn DL, Ryder JW, Myers AM, O'Brien RF. Pulmonary non-Hodgkin's lymphoma in AIDS. Chest 1989; 96: 1321-6.
70. Nyberg DA, Jeffrey RB Jr, Federle MP, Bottles K, Abrams DI. AIDS-related lymphomas: evaluation by abdominal CT. Radiology 1986; 159: 59-63.
71. Podzamczer D, Ricart I, Bolao F, et al. Gallium-67 scan for distinguishing follicular hyperplasia from other AIDS-associated diseases in lymph nodes. AIDS 1990; 4: 683-5.
72. Martin-Bates E, Tanner A, Suvarna S, Glazer G, Coleman D. Use of fine needle aspiration cytology for investigating lymphadenopathy in HIV positive patients. J Clin Pathol 1993; 46: 564-6.
73. Bissuel F, Leport C, Perronne C, Longuet P, Vilde J. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med 1994; 236: 529-35.
74. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112-35.
75. Herndier BG, Kaplan LD, McGrath MS. Pathogenesis of AIDS lymphomas. AIDS 1994; 8: 1025-49.
76. Carbone A, Glgohini A, Gaidano G, et al. AIDS-related Burkitt's lymphoma: morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol 1995; 103: 561-7.
77. Raphael M, Audouin J, Lamine M, et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Am J Clin Pathol 1994; 101: 773-82.
78. Pittaluga S, Bijnens L, Teodorovic I, et al. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation. Blood 1996; 87: 4358-67.
79. McGrath MS, Shiramizu B, Meeker TC, Kaplan LD, Herndier B. AIDS-associated polyclonal lymphoma: identification of a new HIV-associated disease process. J Acquir Immune Defic Syndr 1991; 4: 408-15.
80. Bermudez M, Grant K, Rodovien R, Mendes F. Non-Hodgkin's lymphoma in a population with or at risk for acquired immunodeficiency syndrome: indications for intensive chemotherapy. Am J Med 1989; 86: 71-6.
81. Levine A, Sullivan-Halley J, Pike M, et al. Human immunodeficiency virus-related lymphoma. Cancer 1991; 68: 2466-72.
82. Kaplan L, Shiramizu B, Herndier B, et al. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome. Blood 1995; 85: 1727-35.
83. Knowles D, Chamulak G, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 108: 744-53.
84. Strauss D, Huang J, Testa M, Levine A, Kaplan L. Prognostic factors in the treament of HIV associated non-Hodgkin's lymphoma: analysis of ACTG142 (low dose vs standard dose mBACOD+GM-CSF). Blood 1995; 86(Suppl): 2404.
85. Irwin D, Kaplan L. Clinical aspects of HIV-related lymphoma. Curr Opin Oncol 1993; 5: 852-60.
86. Dugan M, Subar M, Odajnyk C, et al. Intensive multiagent chemotherapy (chemo) for AIDS-related diffuse large cell lymphomas (LCL). Blood 1986; 68: 124a.
87. Odajnyk C, Subar M, Dugan M, et al. Clinical features and correlation with immunopathology and molecular biology in a large group of patients with AIDS-associated small non-cleaved cell lymphoma, Burkitt's and non-Burkitt's type. Blood 1986; 68: 131a.
88. Gill P, Levine A, Krailo M, et al. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol 1987; 5: 1322-8.
89. Sawka CA, Shepherd FA, Brandwein J, Burkes RL, Sutton DM, Warner E. Treatment of AIDS-related non-Hodgkin's lymphoma with a twelve week chemotherapy program. Leuk Lymphoma 1992; 8: 213-20.
90. Levine A, Wernz J, Kaplan L, et al. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. JAMA 1991; 266: 84-8.
91. Levine A, Espina B, Tulpule A, et al. Low dose m-Bacod with concomitant dideoxycytidine (ddC): an effective regimen in AIDS related lymphoma. Blood 1992; 78: 387a.
92. Kaplan L, Straus D, Testa M, et al. Low dose compared to standard dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. N Engl J Med 1997; 336: 1641-6.
93. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002-6.
94. Kaplan L, Kahn J, Crowe S, et al. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. J Clin Oncol 1991; 9: 929-40.
95. Tirelli U, Errante D, Oksenhendler E, et al. Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poor-prognosis AIDS-related non-Hodgkin's lymphoma. French-Italian Cooperative Study Group. Ann Oncol 1992: 843-7.
96. Walsh C, Wernz JC, Levine A, et al. Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr 1993; 6: 265-71.
97. Gabarre J, Lepage E, Thyss A, et al. Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphoma. Ann Oncol 1995; 6: 1025-32.
98. Matsushima Y, Kanzaw F, Hoshi A, et al. Time schedule dependancy of the inhibiting activity of various anticancer drugs in the clonogenic assay. Cancer Chemother Pharmacol 1985; 14: 104-7.
99. Sparano J, Wiernik P, Strack M, Leaf A, Becker N, Valentine E. Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen. Blood 1993; 8: 2810-5.
100. Laporte J, Lesage S, Woler M, et al. Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high-grade lymphoma. Eur J Haematol 1994; 53: 123-5.
101. Saral R, Holland H. Bone marrow transplantation for the acquired immune deficiency syndrome. In: Forman S, Blume K, Thomas E, eds. Bone Marrow Transplantation. Boston: Blackwell; 1994: 654-64.
102. Contu L, La Nasa G, Arras M, et al. Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS. Bone Marrow Transplant 1993; 12: 669-71.
103. Cooper MH, Maraninchi D, Gastaut JA, Mannoni P, Carcassonne Y. HIV infection in autologous and allogeneic bone marrow transplant patients: a retrospective analysis of the Marseille bone marrow transplant population. J Acquir Immune Defic Syndr 1993; 6: 277-84.
104. Holland H, Saral R, Rossi J, et al. Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med 1989; 111: 973-81.
105. Torlontano G, Di BP, Di GG, et al. AIDS-related complex treated by antiviral drugs and allogeneic bone marrow transplantation following conditioning protocol with busulphan, cyclophosphamide and cyclosporin. Haematologica 1992; 77: 287-90.
106. Sparano JA, Wiernik PH, Hu X, et al. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma. J Clin Oncol 1996; 14: 3026-35.
107. Levine AM, Tulpule A, Espina B, et al. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Cancer 1996; 78: 517-26.
108. Deeks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors. A review for clinicians. JAMA 1997; 277: 145-53.
109. Mazza P, Bocchia M, Tumietto F, et al. Recombinant interleukin-2 (rIL-2) in acquired immune deficiency syndrome (AIDS): preliminary report in patients with lymphoma associated with HIV infection. Eur J Haematol 1992; 49: 1-6.
110. Bernstein Z, Porter M, Gould M, et al. Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. Blood 1995; 86: 3287-94.
111. Blumberg RS, Paradis TJ, Crawford D, Byington RE, Hirsch MS, Schooley RT. Effects of human immunodeficiency virus (HIV) on the cytotoxic response to Epstein Barr virus (EBV) transformed B lymphocytes. AIDS Res Hum Retroviruses 1987; 3: 303-15.
112. Boyle R, Berend K, DiMaio J, Coles R, Via D, Lyerly H. Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma. Surgery 1993; 114: 218-26.
113. Heslop H, Brenner M, Rooney C. Donor T cells to treat EBV-associated lymphoma. N Engl J Med 1994; 331: 679-80.
114. Heslop H, Brenner M, Rooney C. Administration of neomycin resistance gene marked EBV specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrealted donor marrow grafts. Hum Gene Ther 1994; 5: 381-97.
115. Wheatley G, Lilly S, Smith C, Moore S, Lyerly H. Treatment of a patient with AIDS related lymphoma with autologous EBV specific cytotoxic T-cells. Ann Snrg (in press).
116. Gill P, Levine A, Meyer P, et al. Primary central nervous system lymphoma in homosexual men: clinical, immunologic, and pathologic features. Am J Med 1985; 78: 742-8.
117. Baumgartner J, Rachlin J, Beckstead J, et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990; 73: 206-11.
118. Ferracini R, Pileri S, Bergmann M, et al. Non-Hodgkin lymphomas of the central nervous system clinico-pathologic and immunohistochemical study of 147 cases. Pathol Res Pract 1993; 189: 249-60.
119. Epstein L, DiCarlo F. Primary lymphoma of the central nervous system in children with acquired immunodeficiency syndrome. Pediatrics 1982; 82: 355-63.
120. Formenti S, Gill P, Lean E, et al. Primary central nervous system lymphoma in AIDS. Cancer 1989; 63: 1101-7.
121. MacMahon EM, Glass JD, Hayward SD, et al. Epstein-Barr virus in AIDS related primary central nervous system lymphoma. Lancet 1991; 338: 969-73.
122. Gill PS, Graham RA, Boswell W, Meyer P, Krailo M, Levine A. A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome. Am J Physiol Imaging 1986; 1: 134-41.
123. Ciricillo SF, Rosenblum ML. Imaging of solitary lesions in AIDS. J Neurosurg 1991; 74: 1029.
124. Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 1986; 19: 224-38.
125. So Y, Beckstead J, Davis R. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol 1986; 20: 566-72.
126. De Luca A, Antinori A, Cincolani A, et al. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995; 90: 844-9.
127. Remick SC, Diamond C, Migliozzi JA, et al. Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature. Medicine 1990; 69: 345-60.
128. Nisce LZ, Kaufmann T, Metroka C. Radiation therapy in patients with AIDS-related central nervous system lymphomas. JAMA 1992; 267: 1921-2.
129. Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD. Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med 1992; 117: 309-11.
130. Kaldor JM, Tindall B, Williamson P, Elford J, Cooper DA. Factors accociated with Kaposi's sarcoma in a cohort of homosexual and bisexual men. J Acquir Immune Defic Syndr 1993; 6: 1145-9.
131. Haverkos HW, Drotman DP, Hanson D. Epidemiology of AIDS-related Kaposi's sarcoma (KS): an update (abstract). Int Conf AIDS 1993; 9: 398.
132. Schechter MT, Marion SA, Elmslie KD, et al. Geographic and birth cohort associations of Kaposi's sarcoma among homosexual men in Canada. Am J Epidemiol 1991; 134: 485-8.
133. Reynolds P, Saunders LD, Layefsky ME, et al. The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco. Am J Epidemiol 1993; 137: 19-30.
134. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335: 123-8.
135. Archibald CP, Schechter MT, Le TN, Craib KJP, Montaner JSG, O'Shaughnessy MV. Evidence for sexually transmited cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men. Epidemiology 1992; 3: 203-9.
136. Mitsuyasu RT, Groopman JE. Biology and therapy of Karposi's sarcoma. Semin Oncol 1984; 11: 53-9.
137. Safai B. Pathophysiology and epidemiology of epidemic Kaposi's sarcoma. Semin Oncol 1987; 14 (Suppl 3): 7-12.
138. Kedes DH, Operkalski E, Busch M, et al. The sero-epidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2: 918-24.
139. Friedman-Kien AE, Saltzman BR, Cao YZ, et al. Kaposi's sarcoma in HIV-negative homosexual men. Lancet 1990; 335: 168-9.
140. Polk BF, Fox R, Brookmeyer R, et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987; 316: 62-6.
141. Drotman DP, Petreman TA, Friedman-Kien AE. Kaposi's sarcoma. How can epidemiology help find the cause? Dermatol Clin 1995; 13: 575-82.
142. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995; 332: 1181-5.
143. Schwartz RA. Kaposi's sarcoma: advances and perspectives. J Am Acad Dermatol 1996; 34: 804-14.
144. Sturzl M, Roth WK, Brockmeyer NH, et al. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci U S A 1992; 89: 7046-50.
145. Brown TJ, Rowe JM, Liu J, Shoyab M. Regulation of IL-6 expression by oncostatin M. J Immunol 1991; 147: 2175-80.
146. Miles SA. Pathogenesis of HIV-related Kaposi's sarcoma. Curr Opin Oncol 1994; 6: 497-502.
147. Albini A, Soldi R, Giunciuglio D, et al. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med 1996; 2: 1371-5.
148. Gill PS, Lunardi IY, Louie S, et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma [published errata appear in N Engl J Med 1997; 336: 670 and 1997; 336: 1115]. N Engl J Med 1996; 335: 1261-9.
149. Chang Y, Ccsarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
150. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995; 1: 707-8.
151. Foreman KE, Friborg JJ, Kong W-P, et al. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med 1997; 336: 163-71.
152. Gao S, Kingsley L, Hoover D, et al. Seroconversion to antibodies against Kaposi's sarcoma herpesvirus-related latent antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335: 233-41.
153. Zalla MJ, Su WP, Fransway AF. Dermatologic manifestations of human immunodeficiency virus infection. Mayo Clin Proc 1992; 67: 1089-108.
154. Levine AM. AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst 1993; 85: 1382-97.
155. Krown SE, Myskowski PL, Paredes J. Kaposi's sarcoma. Med Clin North Am 1992; 76: 235-52.
156. Yee J, Wall SD. Gastrointestinal manifestations of AIDS. Gastroenterol Clin North Am 1995; 24: 413-34.
157. Wall SD, Friedman SL, Margulis AR. Gastrointestinal Kaposi's sarcoma in AIDS: radiographic manifestations. J Clin Gastroenterol 1984; 6: 165-71.
158. Friedman SL, Wright TL, Altman DF. Gastrointestinal Karposi's sarcoma in patients with acquired immunodeficiency syndrome: endoscopic and autopsy findings. Gastroenterology 1985; 89: 102-8.
159. Luburich P, Bru C, Ayuso MC, et al. Hepatic Kaposi sarcoma in AIDS: US and CT findings. Radiology 1990; 175: 172-4.
160. Lowy AM, Barie PS. Laparotomy in patients infected with human immunodeficiency virus; indications and outcome. Br J Surg 1994; 81: 942-45.
161. Meduri GU, Stover DE, Lee M, et al. Pulmonary KS in AIDS. Am J Med 1986; 81: 11-8.
162. Cadranel JL, Kammoun S, Chevert S, et al. Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax 1994; 49: 958-60.
163. Denton AS, Miller RF, Spittle MF. Management of pulmonary Kaposi's sarcoma: new perspectives. Br J Hosp Med 1995; 53: 344-50.
164. Kaplan LD, Hopewell PC, Jaffe H, et al. Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1988; 1: 23-30.
165. Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immunodeficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 1989; 7: 1201-7.
166. Krown SE, Testa M, Huang J. Validation of the AIDS clinical trials group staging classification for AIDS-associated Kaposi's sarcoma (abstract). Proc Am Soc Clin Oncol 1996; 15: 303.
167. Piedbois P, Frikha H, Martin L, Levy E, Haddad E, LeBourgeois JP. Radiotherapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1994; 30: 1207-11.
168. Meyer JH. Whole lung irradiation for Kaposi's sarcoma. Am J Clin Oncol 1993; 16: 372-6.
169. Wang CY, Schroeter AL, Su WP. Acquired immunodeficiency syndrome related Kaposi's sarcoma. Mayo Clin Proc 1995; 70: 869-79.
170. Vom MD, Von Roenn JH. Treatment strategies for epidemic Kaposi's sarcoma. Curr Opin Oncol 1995; 7: 429-36.
171. Tappero JW, Berger TG, Kaplan LD, et al. Cryotherapy for cutaneous Kaposi's sarcoma associated with acquired immune deficiency syndrome (AIDS): a phase II trial. J Acquir Immune Defic Syndr 1991; 4: 839-46.
172. Real FX, Krown SE, Oettgen HF. Kaposi's sarcoma and the accuired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte α interferon. J Clin Oncol 1986; 4: 544-51.
173. Mitsuyasu RT. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma. Br J Haematol 1991; 79 (Suppl 1): 69-73.
174. Scadden DT, Bering HA, Levine JD, et al. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma. Am J Clin Oncol 1991; 14 (Suppl 1): S40-4.
175. Laubenstein LJ, Krigel RL, Odanjnyk CM, et al. Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 1984; 2: 1115-20.
176. Gill PS, Rarick MU, Espina B, et al. Systematic treatment of AIDS-related Kaposi's sarcoma; results of a randomized trial. Am J Med 1991; 90: 427-33.
177. Saville MW, Lietzau J, Pluda JM, et al. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 1995; 346: 26-8.
178. Welles L, Saville MW, Lietzau J, et al. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 1998; 16: 1112-21.
179. Harrison M, Tomlinson D, Stewart S. Liposomal-entrapped doxorubicin; an active agent in AIDS-related Kaposi's sarcoma. J Clin Oncol 1995; 13: 914-20.
180. Gill PS, Wernz J, Scadden DT, et al. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol 1996; 14: 2353-64.
181. Wit FW, Sol CJ, Renwick N, et al. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy (letter). AIDS 1998; 12: 218-9.
182. Maiman M, Fruchter RG, Clark M, Arrastia CD, Matthews R, Gates EJ. Cervical cancer as an AIDS-defining illness. Am J Obstet Gynecol 1997; 89: 76-80.
183. Adachi A, Fleming I, Burk RD, Ho GYF, Klein RS. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome. Obstet Gynecol 1993; 81: 372-7.
184. Maiman M, Frachter RG, Serur E, Levine PA, Arrastia CD, Sedlis A. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 1993; 82: 170-1.
185. Northfelt DW. Cervical and anal neoplasia and HPV infection in persons with HIV infection. Oncology (Huntingt) 1994; 8: 33-7.
186. Maiman M, Fruchter RG, Serur E, Remy JC, Feuer G, Boyce J. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 1990; 38: 377-82.
187. Boccalon M, Tirelli U, Sopracordevole F, Vaccher E. Intraepithelial and invasive cervical neoplasia during HIV infection. Enr J Cancer 1996; 32A: 2212-7.
188. Rellihan MA, Dooley DP, Burke TW, Berkland ME, Longfield RN. Rapidly progressing cervical cancer in a patient with human immunodeficieny virus infection. Gynecol Oncol 1990; 36: 435-8.
189. Schwartz LB, Carcangiu ML, Bradham L, Schwartz PE. Rapidly progressive squamous cell carcinoma of the cervix coexisting with human immunodeficiency virus infection: clinical opinion. Gynecol Oncol 1991; 41: 255-8.
190. Melbye M, Rabkin C, Frisch M, Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 1994; 139: 772-80.
191. Northfeldt D. Anal neoplasia in persons with HIV infection. AIDS Clinical Care 1996; 8: 63-6.
192. Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994; 8: 283-95.
193. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infectin and risk of anal and cervical epithelial abnormalties in human immunodeficiency virus-infected women. Am J Obstet Gynecol 1994; 83: 205-11.
194. Melbye M, Cote TR, Kessler L, Gail M, Biggar RJ. High incidence of anal cancer among AIDS patients. The AIDS/ Cancer Working Group. Lancet 1994; 343: 636-9.
195. DiSaia PJ, Creasman WT. Management of endometrial adenocarcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy. Clin Obstet Gynaecol 1986; 13: 751-65.
196. Genital human papillomavirus infections. Int J Obstet Gynecol 1994; 46: 339-15.
197. Puthenveettil JA, Frederickson SM, Reznikoff CA. Apoptosis in human papillomavirus16 E7-, but not E6-immortalized human uroepithelial cells. Oncogene 1996; 13: 1123-31.
198. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-9.
199. Halpert R, Fruchter RG, Sedlis A, Butt K, Boyce JG, Sillman FH. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986; 68: 251-8.
200. Johnson JC, Burnett AF, Willet GD, Young MA, Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in human immunodeficiency virus-infected women. Am J Obstet Gynecol 1992; 79: 321-7.
201. Klein RS, Ho GY, Vermund SH, Fleming I, Burk RD. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 1994; 170: 1404-9.
202. Spinillo A, Tenti P, Rao S, Zappatore R, Romagnoli S, Pizzoli G. Nucleolar organizer regions and cervical intraepithelial neoplasia among women with human immunodeficiency virus infection. Am J Obstet Gynecol 1994; 171: 773-7.
203. Wright TCJ, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol 1994; 84: 591-7.
204. Maiman M, Tarricone N, Vieira J, Suarcz J, Serur E, Boyce JG. Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstet Gynecol 1991; 78: 84-8.
205. Boardman LA, Peipert JF, Cooper AS, Cu-Uvin S, Flanigan T, Raphael SI. Cytologic-histologic discrepancy in human immunodeficiency virus-positive women referred to a colposcopy clinic. Obstet Gynecol 1994; 84: 1016-9.
206. Heard I, Bergeron C, Jeannel D, Henrion R, Kazatchkine MD. Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up. Obstet Gynecol 1995; 86: 749-53.
207. Korn AP, Autry M, DeRemer PA, Tan W. Sensitivity of the Papanicolaou smear in human immunodeficiency virus infected women. Obstet Gynecol 1994; 83: 401-4.
208. Wright TCJ, Moscarelli RD, Dole P, Ellerbrock TV, Chiasson MA, VanDevanter N. Significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet Gynecol 1996; 87: 515-9.
209. von Krogh G, Wikstrom A, Syrjänen K, Syrjänen S. Anal and penile condylomas in HIV-negative and HIV-positive men: clinical, histological and virological characteristics correlated to therapeutic outcome. Acta Derm Venereol 1995; 75: 470-4.
210. Carter PS, de Ruiter A, Whatrup C, et al. Human immunodeficiency virus infection and genital warts as risk factors for anal intraepithelial neoplasia in homosexual men. Br J Surg 1995; 82: 473-4.
211. Surawicz CM, Critchlow C, Sayer J, et al. High grade anal dysplasia in visually normal mucosa in homosexual men: seven cases. Am J Gastroenterol 1995; 90: 1776-8.
212. Holland J, Swift P. Tolerance of patients with HIV and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology 1994; 193: 251-4.